Strategy - Pharmaceutical Executive

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Strategy
The art and science of running a successful pharmaceutical company.

Lean Comes to Pharma

November 18, 2009

The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?

Are You Ready For The Revolution?

November 11, 2009

Seven Global Trends shaping the future of the pharmaceutical industry.

Pfizer Quick on the Draw with R&D Location Plans

November 11, 2009

Following through with its promise to waste no time in merging Wyeth and Pfizer, the pharma giant announced restructuring plans for its global research network.

GSK Donates 50 Million H1N1 Doses To WHO

November 11, 2009

Developing countries will receive the scarce vaccine for free, as GSK remains confident it will fulfill contractual vaccine obligations around the world.

Applying FDA Regulations to Online Marketing

November 9, 2009

This guide aims to provide pharma marketers with an overview of the key challenges surrounding Direct-to-Consumer (DTC) online marketing and some potential solutions for effectively leveraging this channel within the complex regulatory environment.

Glaxo Vies for a Second Act in HIV

November 4, 2009

A novel joint venture between Glaxo and Pfizer is big on promise. But the combined portfolio and pipeline of HIV drugs? Not so much.

Innovation Over Imitation

November 4, 2009

As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics.

J&J Cuts Staff in Major Restructuring Move

November 4, 2009

Johnson & Johnson announced a massive restructuring plan on Tuesday in an effort to save $1.4 billion to $1.7 billion by 2011. The human cost: 7 percent of its workforce.

Global Pharma Market Growth to Grow 4 to 6 Percent in 2010

October 8, 2009

Sure, industry growth is at "historically low levels," but at least pharma is still growing. The industry's market value should surpass $825 billion in 2010, and forecasted growth was bumped up one percentage point from original estimates.

ADVERTISEMENT

Click here